Health ❯ Healthcare ❯ Clinical Trials

Regulatory Approval

FDA Designations Lecanemab Ethical Review Drug Development Pipeline FDA Submission FDA Trials Drug Development EU Drug Approval DCGI Medical Innovations Clinical Trial Waivers FDA Process Drug Commercialization FDA Processes

Agios’ Sickle Cell Pill Lifts Hemoglobin but Misses Pain-Crisis Goal in Phase 3

The mixed efficacy leaves mitapivat’s expansion prospects uncertain during an FDA review in beta thalassemia that targets a Dec. 7 decision.

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

Indomo's ClearPen, an At-Home Acne Steroid Injector, Set for Phase 2 Trial Next Year

Hot-Glue-Gun Device 3D-Prints Bone Implants in Surgery With Promising Rabbit Results